Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).
Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).
Project description:This SuperSeries is composed of the following subset Series: GSE23999: Mapping the binding regions of the cubitus interruptus (Ci) activator form GSE24024: Mapping the binding regions of the cubitus interruptus (Ci) repressor form GSE24028: Identification of genetic targets of Hh signaling in Drosophila Refer to individual Series
